[go: up one dir, main page]

NO20084187L - Medikamenter og proteiner - Google Patents

Medikamenter og proteiner

Info

Publication number
NO20084187L
NO20084187L NO20084187A NO20084187A NO20084187L NO 20084187 L NO20084187 L NO 20084187L NO 20084187 A NO20084187 A NO 20084187A NO 20084187 A NO20084187 A NO 20084187A NO 20084187 L NO20084187 L NO 20084187L
Authority
NO
Norway
Prior art keywords
drugs
medications
proteins
fragments
derivatives
Prior art date
Application number
NO20084187A
Other languages
English (en)
Norwegian (no)
Inventor
Mark William James Ferguson
Hugh Gerard Laverty
Nick Occleston
Sharon O'kane
Emma Atkinson
Phillip Mellors
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of NO20084187L publication Critical patent/NO20084187L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20084187A 2006-03-11 2008-10-07 Medikamenter og proteiner NO20084187L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0604966.2A GB0604966D0 (en) 2006-03-11 2006-03-11 Medicaments and proteins
PCT/GB2007/000834 WO2007104946A2 (en) 2006-03-11 2007-03-12 Medicaments and proteins based on tgf-beta monomers for the treatment of wounds

Publications (1)

Publication Number Publication Date
NO20084187L true NO20084187L (no) 2008-10-07

Family

ID=36241467

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084187A NO20084187L (no) 2006-03-11 2008-10-07 Medikamenter og proteiner

Country Status (13)

Country Link
US (1) US7902150B2 (ru)
EP (2) EP2012812A2 (ru)
JP (1) JP2009543757A (ru)
KR (1) KR20080100828A (ru)
CN (1) CN101605555A (ru)
AR (1) AR062773A1 (ru)
BR (1) BRPI0708791A2 (ru)
GB (1) GB0604966D0 (ru)
IL (1) IL193700A0 (ru)
MX (1) MX2008011707A (ru)
NO (1) NO20084187L (ru)
RU (1) RU2008140117A (ru)
WO (1) WO2007104946A2 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009221164A (ja) * 2008-03-17 2009-10-01 Nitto Denko Corp 肺線維症処置剤
PT2730277T (pt) 2004-12-22 2020-04-21 Nitto Denko Corp Veículo de fármaco e kit de veículo de fármaco para a inibição da fibrose
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0724204D0 (en) * 2007-12-12 2008-01-23 Renovo Ltd Methods for inhibition of scarring
GB0724203D0 (en) * 2007-12-12 2008-01-23 Renovo Ltd Methods for the inhibition of scarring
MX365647B (es) * 2011-02-02 2019-06-10 Excaliard Pharmaceuticals Inc El uso de compuestos antisentido dirigidos al factor de crecimiento del tejido conectivo (ctgf) para tratar queloides o cicatrices hipertroficas.
JP7531887B2 (ja) * 2020-07-31 2024-08-13 学校法人関西医科大学 ＴＧＦ－βを含む組織の線維化抑制剤
WO2023069629A1 (en) * 2021-10-20 2023-04-27 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods of treating inflammatory bowel disease
WO2023206188A1 (en) * 2022-04-28 2023-11-02 Wenzhou Prarucom Bio-Chemical Technology Co. Method for alleviating pulmonary fibrosis using epidermal growth factor
CN115715798A (zh) * 2022-07-05 2023-02-28 上海交通大学医学院附属第九人民医院 用于糖尿病创面修复的细胞因子及其应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051848A (en) * 1976-03-01 1977-10-04 Levine Norman S Synthetic skin wound dressing
IL78197A (en) 1985-03-22 1991-07-18 Genentech Inc Nucleic acid encoding tgf-beta and its uses
US6559123B1 (en) * 1985-04-19 2003-05-06 Osi Pharmaceuticals, Inc. Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
US5135915A (en) * 1988-10-14 1992-08-04 Genentech, Inc. Method for the treatment of grafts prior to transplantation using TGF-.beta.
AU6870791A (en) 1989-10-18 1991-05-16 Creative Biomolecules, Inc. Biosynthetic constructs of tgf-beta
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
GB9206861D0 (en) 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
AU3943793A (en) * 1992-04-01 1993-11-08 Whittier Institute For Diabetes And Endocrinology, The Methods of inhibiting or enhancing scar formation in the CNS
US5411940A (en) * 1993-09-29 1995-05-02 Alcon Laboratories, Inc. Use of TGF-β3 to reduce the formation of scar tissue in response to corneal trauma
US5399677A (en) 1993-12-07 1995-03-21 Genetics Institute, Inc. Mutants of bone morphogenetic proteins
TW440566B (en) 1994-07-25 2001-06-16 Novartis Ag Novel process for the production of biologically active dimeric protein
TW517059B (en) * 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
US6294656B1 (en) * 1995-07-25 2001-09-25 Novartis Corporation Transforming growth factor β crystals
US6084076A (en) 1995-12-21 2000-07-04 Ajinomoto Co., Inc. Method of refolding human activin A
CA2251129A1 (en) * 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
JPH11335398A (ja) * 1998-05-22 1999-12-07 Hoechst Marion Roussel Kk 新規な骨誘導活性を有する単量体蛋白質およびそれらからなる軟骨・骨疾患の予防および治療薬
EP1074620A1 (en) * 1999-08-06 2001-02-07 HyGene AG Monomeric protein of the TGF-beta family
US20020052026A1 (en) 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
AU5087799A (en) * 1998-07-06 2000-01-24 Beth Israel Deaconess Medical Center Methods of inhibiting proliferative diseases by inhibiting tgf-beta mediated angiogenesis
CA2344269A1 (en) 1998-10-07 2000-04-13 Syngenta Participations Ag Therapeutically active proteins in plants
US6677432B1 (en) 1998-10-07 2004-01-13 Stryker Corporation Mutations of the C-terminal portion of TGF-β superfamily proteins
JP2002539172A (ja) 1999-03-17 2002-11-19 ノバルティス アクチエンゲゼルシャフト Ｔｇｆ−ベータを含む医薬組成物
WO2000056879A1 (en) * 1999-03-22 2000-09-28 Universität Zürich TRANSFORMING GROWTH FACTOR (TFG) β SUPERFAMILY ANTAGONISTS
WO2001075132A2 (en) 2000-04-03 2001-10-11 Monsanto Technology Llc Method for producing authentic cytokines in plants
EP1279677B1 (en) * 2000-04-25 2007-03-07 Otsuka Pharmaceutical Co., Ltd. Gd3-mimetic peptides
US20040078851A1 (en) * 2000-05-02 2004-04-22 Ning Huang Production of human growth factors in monocot seeds
DE10026713A1 (de) 2000-05-30 2001-12-06 Walter Sebald Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
WO2002012336A2 (en) * 2000-08-09 2002-02-14 Curis, Inc. TGF-β THERAPEUTICS, COMPOSITIONS AND METHODS OF USE
CA2441588A1 (en) 2001-03-23 2002-10-03 Biopharm Gesellschaft Zue Biotechnologischen Entwicklung Von Pharmaka Mbh Use of cytokines of the tgf-.beta. superfamily for the treatment and diagnosis of skin related disorders
JP2005525081A (ja) 2001-06-05 2005-08-25 カレン ケイ． オオイシ 植物からの生物活性ミュラー管抑制物質を含むＴＧＦ−βタンパク質の遺伝子発現および産生法
KR20050054928A (ko) 2002-09-27 2005-06-10 센트로 데 인제니에리아 제네티카 와이 바이오테크놀로지아 피자식물의 유전자 형질전환 식물의 생산용 벡터
CA2558667A1 (en) * 2004-02-27 2005-09-15 Antisense Pharma Gmbh Antisense oligonucleotides for inhibiting the formation of metastases in cancer
ATE472333T1 (de) 2004-08-19 2010-07-15 Biogen Idec Inc Rückfaltung von proteinen der transforming-growth-factor-beta-familie
US20060162026A1 (en) 2004-12-23 2006-07-20 Karen Oishi Expressing TGF-beta proteins in plant plastids
GB0514262D0 (en) * 2005-07-12 2005-08-17 Renovo Ltd Promotion of epithelial regeneration
BRPI0613731A2 (pt) * 2005-07-12 2011-02-01 Renovo Ltd composição farmacêutica, recipiente enchido previamente, bem como uso de um açúcar para aprimorar a recuperação e/ou aumentar a atividade biológica de um membro da superfamìlia tgf-beta
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0617816D0 (en) 2006-09-11 2006-10-18 Renovo Ltd Nucleic acids and methods of protein expression

Also Published As

Publication number Publication date
IL193700A0 (en) 2011-08-01
BRPI0708791A2 (pt) 2011-06-14
CN101605555A (zh) 2009-12-16
AR062773A1 (es) 2008-12-03
WO2007104946A3 (en) 2008-04-24
EP2012812A2 (en) 2009-01-14
WO2007104946A2 (en) 2007-09-20
KR20080100828A (ko) 2008-11-19
EP2359844A2 (en) 2011-08-24
US7902150B2 (en) 2011-03-08
EP2359844A3 (en) 2011-09-14
MX2008011707A (es) 2008-09-26
US20090137475A1 (en) 2009-05-28
RU2008140117A (ru) 2010-04-20
JP2009543757A (ja) 2009-12-10
GB0604966D0 (en) 2006-04-19

Similar Documents

Publication Publication Date Title
NO20084187L (no) Medikamenter og proteiner
NO20092527L (no) Prolegemidler, fremgangsmate for fremstilling og anvendelse derav
CY1112813T1 (el) 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων
MY143407A (en) Indazole derivatives as inhibitors of hormone sensitive lipase
UY30794A1 (es) Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinic0
PH12017502286A1 (en) Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
TW200728285A (en) Diacylindazole derivatives as inhibitors of lipases and phospholipases
NO20065195L (no) Terapeutiske enzymformuleringer og anvendelser derav
DK1543063T3 (da) Medikament levering
NO20092254L (no) Pulverformuleringer for valganciclovir
CL2011003327A1 (es) Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales.
BR0311700A (pt) Processo para a produção de uma preparação em forma de pelìcula e preparação em forma de pelìcula
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
NO20080035L (no) Benzooksazol-2-on derivater som lipase og fosfolipaseinhibitorer
ATE451934T1 (de) Pharmazeutische zusammensetzung zur behandlung von rhinitiden
DK1771155T3 (da) Fremgangsmåde og sammensætning til behandling af rhinitis
CY1118967T1 (el) Φαρμακευτικες συνθεσεις υψηλης δοσης βιοτινης
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
NO20080034L (no) Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorer
ATE446098T1 (de) Verwendung von polyethylenglycol bei entzündungsbedingten topischen erkrankungen oder erkrankungen und wundheilung
NO20082838L (no) 9-klor-15-deoksyprostaglandinderivater, fremgangsmate for fremstilling av disse, og anvendelse som medikamenter
AU2002346594A1 (en) Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation
EA200602002A1 (ru) Применение спинозинов для заживления ран
NO20044321L (no) Piperazinyl- eller piperidinylamin-sulfaminsyreamider som inhibitorer av steroid sulfatase
WO2007108004A8 (en) S-alkylisothiouronium derivatives for the treatment of inflammatory diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application